OpenLB
Open Library of Bioscience
Advanced Search

Journal

Publication Year

1 year 3 years 5 years 10 years
2021 - 2032
202120222023
202420252026
202720282029
203020312032
2021 - 2032
202120222023
202420252026
202720282029
203020312032

Publication Type

Associated Data

Found 7,520 results

Filters: Liraglutide

Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial.
Chantal Mathieu, Bernard Zinman, Joanna Uddén Hemmingsson, Vincent Woo, Peter Colman, Erik Christiansen, Martin Linder, Bruce Bode, ADJUNCT ONE Investigators
Diabetes Care. Oct, 2016.39(10):1702-10 Print-Electronic
Source:PubMed
PMID: 27506222 doi:10.2337/dc16-0691
[Liraglutide].
Tomono Takahashi, Masato Odawara
Nihon Rinsho. May, 2011.69(5):883-9 Print
Source:PubMed
PMID: 21595276 doi:
Liraglutide for the prevention of major adverse cardiovascular events in diabetic patients.
Sten Madsbad
Expert Rev Cardiovasc Ther. May, 2019.17(5):377-387 Print-Electronic
Source:PubMed
PMID: 31055989 doi:10.1080/14779072.2019.1615444
Liraglutide: clinical pharmacology and considerations for therapy.
Evan M Sisson
Pharmacotherapy. Sep, 2011.31(9):896-911 Print
Source:PubMed
PMID: 21923591 doi:10.1592/phco.31.9.896
Liraglutide: a new treatment for type 2 diabetes.
Tina Vilsboll
Drugs Today (Barc). Feb, 2009.45(2):101-13 Print
Source:PubMed
PMID: 19343230 doi:10.1358/dot.2009.45.2.1336104
Liraglutide in type 2 diabetes mellitus.
Manash P Baruah, Tirthankar Chaudhury, Bipin Kumar Sethi, Mala Dharmalingam
J Indian Med Assoc. May, 2012.110(5):335-8 Print
Source:PubMed
PMID: 23360033 doi:
Durable efficacy of liraglutide in patients with type 2 diabetes and pronounced insulin-associated weight gain: 52-week results from the Effect of Liraglutide on insulin-associated wEight GAiN in patients with Type 2 diabetes' (ELEGANT) randomized controlled trial.
H M de Wit, G M Vervoort, H J Jansen, B E de Galan, C J Tack
J Intern Med. Mar, 2016.279(3):283-92 Print-Electronic
Source:PubMed
PMID: 26553486 doi:10.1111/joim.12447
liraglutide (SAXENDA⁰) and obesit. Still no satisfactory weight loss drugs.
No authors listed
Prescrire Int. Jan, 2016.25(167):5-8 Print
Source:PubMed
PMID: 26942248 doi:
Clinical pearls for initiating and utilizing liraglutide in patients with type 2 diabetes.
Benjamin Gross
J Pharm Pract. Apr, 2013.26(2):144-50 Print-Electronic
Source:PubMed
PMID: 23204146 doi:10.1177/0897190012465985
The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1-5 studies.
L Blonde, D Russell-Jones
Diabetes Obes Metab. Dec, 2009.11 Suppl 3:26-34 Print
Source:PubMed
PMID: 19878259 doi:10.1111/j.1463-1326.2009.01075.x
0